Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Charles River Laboratories Intl (CRL)
NYSE:CRL
Charles River Labs (CRL) Ownership Overview
0.99% Insiders
31.65% Mutual Funds
32.89% Other Institutional Investors
25.22% ETFs
9.26% Public Companies and Individual Investors
The ownership structure of Charles River Labs (CRL) stock is a mix of institutional, retail, and individual investors. Approximately 89.75% of the company’s stock is owned by Institutional Investors, 0.99% is owned by Insiders, and 9.26% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 21, 2025 | James C. Foster Cob, Pres & Ceo,director | xxxxxxxxxxxxx | $1002436 |
| Feb 21, 2025 | Birgit Girshick Corporate Executive Vp & Coo | xxxxxxxxxxxxx | $249250 |
| Feb 21, 2025 | Joseph W Laplume Evp, Corp Strategy & Develop | xxxxxxxxxxxxx | $715000 |
| Nov 12, 2024 | Richard Wallman Director | xxxxxxxxxxxxx | $1647418 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $7199400 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $42885902 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,539,006 | Institution | 10.83% | 841,873,522 | |
| 4,998,573 | Institution | 9.78% | 759,733,110 | |
| 2,445,513 | Institution | 4.78% | 371,693,521 | |
| 1,999,115 | Institution | 3.91% | 303,845,489 | |
| 1,852,440 | Institution | 3.62% | 281,552,356 | |
| 1,443,049 | Institution | 2.82% | 219,329,018 | |
| 1,115,889 | Institution | 2.18% | 169,603,969 | |
| 1,067,327 | Institution | 2.09% | 162,223,031 | |
| 1,003,472 | Institution | 1.96% | 152,517,709 | |
| 935,820 | Institution | 1.83% | 142,235,282 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,998,573 | Institution | 9.78% | 759,733,110 | |
| 1,999,115 | Institution | 3.91% | 303,845,489 | |
| 1,443,049 | Institution | 2.82% | 219,329,018 | |
| 932,186 | Institution | 1.82% | 141,682,950 | |
| 841,162 | Institution | 1.64% | 127,848,212 | |
| 569,361 | Institution | 1.11% | 86,537,178 | |
| 410,461 | Institution | 0.80% | 62,385,967 | |
| 368,785 | Institution | 0.72% | 56,051,632 | |
| 357,667 | Institution | 0.70% | 54,361,807 | |
| 326,018 | Institution | 0.64% | 49,551,476 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,598,548 | Institution | 3.13% | 295,091,961 | |
| 1,385,020 | Institution | 2.71% | 255,674,692 | |
| 1,302,182 | Institution | 2.55% | 240,382,797 | |
| 776,925 | Institution | 1.52% | 118,084,831 | |
| 626,780 | Institution | 1.23% | 96,003,893 | |
| 626,780 | Institution | 1.23% | 96,003,893 | |
| 599,256 | Institution | 1.17% | 91,080,919 | |
| 431,799 | Institution | 0.84% | 79,710,095 | |
| 369,304 | Institution | 0.72% | 68,173,518 | |
| 363,064 | Institution | 0.71% | 55,610,513 |
FAQ
Who Owns Charles River Laboratories Intl (CRL)?
According to the latest TipRanks data, approximately 32.89% of the company's stock is held by institutional investors, 0.99% is held by insiders, and 9.26% is held by retail investors.
What percentage of Charles River Laboratories Intl (CRL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 32.89% of Charles River Laboratories Intl (CRL) stock is held by institutional investors.
What percentage of Charles River Laboratories Intl (CRL) stock is held by retail investors?
According to the latest TipRanks data, approximately 9.26% of Charles River Laboratories Intl (CRL) stock is held by retail investors.
Who owns the most shares of Charles River Laboratories Intl (CRL)?
Vanguard owns the most shares of Charles River Laboratories Intl (CRL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.